Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease

References

• AbramsonJSSpikaJS1985Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal diseaseJ Infect Dis15137013918127
   PubMed Web of Science ®Google Scholar
• BarquetNDomingoP1999Meningococcal disease in a large urban population (Barcelona, 1987–1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance GroupArch Intern Med15923294010547173
   PubMedGoogle Scholar
• BilukhaOORosensteinN2005Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Recomm Rep54RR-712115917737
   PubMedGoogle Scholar
• BorrowRAndrewsN2001Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protectionInfect Immun6915687311179328
   PubMed Web of Science ®Google Scholar
• BorrowRBalmerP2005Meningococcal surrogates of protection – serum bactericidal antibody activityVaccine232222715755600
   PubMed Web of Science ®Google Scholar
• BorrowRMillerE2006Long-term protection in children with meningococcal C conjugate vaccination: lessons learnedExpert Rev Vaccines5851717184222
   PubMed Web of Science ®Google Scholar
• BruceMGRosensteinNE2001Risk factors for meningococcal disease in college studentsJAMA2866889311495618
   PubMed Web of Science ®Google Scholar
• CampbellJDEdelmanR2002Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adultsJ Infect Dis18618485112447774
   PubMed Web of Science ®Google Scholar
• [CDC] Centers for Disease Control and Prevention2007Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2006 [online]. Accessed 26 Mar 2008. URL: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening06.pdf
   Google Scholar
• ClarkT2007Meningococcal conjugate vaccine and Guillain Barre syndromeAdvisory Committee on Immunization Practices meetingOct 24 2007Atlanta, Georgia, USA
   Google Scholar
• CondonRJRileyTV1994Invasive meningococcal infection after splenectomyBMJ30879238142850
   PubMed Web of Science ®Google Scholar
• DanzigL2004Meningococcal vaccinesPediatr Infect Dis J2312 SupplS2859215597071
   PubMedGoogle Scholar
• El BashirHHeathPT2006Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccineVaccine242544916417952
   PubMed Web of Science ®Google Scholar
• EU-IBIS2006Invasive Neisseria meningitidis in Europe – 2006 [online]. Accessed Apr 5 2008. URL: www.euibis.org
   Google Scholar
• GardnerP2006Clinical practice. Prevention of meningococcal diseaseN Engl J Med35514667317021322
   PubMed Web of Science ®Google Scholar
• GirgisNFrenckRWJr1998Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis.Pediatr Infect Dis J1781699779768
   PubMed Web of Science ®Google Scholar
• GoldschneiderIGotschlichEC1969aHuman immunity to the meningococcus. I. The role of humoral antibodiesJ Exp Med1291307264977280
   PubMed Web of Science ®Google Scholar
• GoldschneiderIGotschlichEC1969bHuman immunity to the meningococcus. II. Development of natural immunityJ Exp Med1291327484977281
   PubMed Web of Science ®Google Scholar
• GotschlichECGoldschneiderI1969Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteersJ Exp Med1291367844977283
   PubMed Web of Science ®Google Scholar
• GranoffDM2004Meningococcal vaccinesPlotkinSAOrensteinWOffitPAVaccines4th edPhiladelphia, PAElsevier-Saunders95987
   Google Scholar
• GranoffDMGuptaRK1998Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccinationJ Infect Dis17887049728562
   PubMed Web of Science ®Google Scholar
• GranoffDMPollardAJ2007Reconsideration of the use of meningococcal polysaccharide vaccinePediatr Infect Dis J267162217848884
   PubMed Web of Science ®Google Scholar
• HahneSGraySJ2002W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001Lancet3595828311867116
   PubMed Web of Science ®Google Scholar
• HarrisonLHDwyerDM1999Risk of meningococcal infection in college studentsJAMA28119061010349894
   PubMed Web of Science ®Google Scholar
• HarrisonLHPassMA2001Invasive meningococcal disease in adolescents and young adultsJAMA286694911495619
   PubMed Web of Science ®Google Scholar
• JodarLFeaversIM2002Development of vaccines against meningococcal diseaseLancet359149950811988262
   PubMed Web of Science ®Google Scholar
• KeyserlingHPapaT2005Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescentsArch Pediatr Adolesc Med1599071316203934
   PubMed Web of Science ®Google Scholar
• MacDonaldNEHalperinSA1998Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trialJAMA280168599832000
   PubMed Web of Science ®Google Scholar
• MaidenMCStuartJM2002Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccinationLancet35918293112044380
   PubMed Web of Science ®Google Scholar
• MMWR2000Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Morb Mortal Wkly Rep49RR0711010993565
   PubMedGoogle Scholar
• MMWR2001aExposure to patients with meningococcal disease on aircrafts – United States, 1999–2001MMWR Morb Mortal Wkly Rep504859
   PubMedGoogle Scholar
• MMWR2001bPublic health dispatch: update: assessment of risk for meningococcal disease associated with the Hajj 2001MMWR Morb Mortal Wkly Rep502212
   PubMedGoogle Scholar
• MMWR2006Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine – United States, June 2005–September 2006MMWR Morb Mortal Wkly Rep551120417060898
   PubMedGoogle Scholar
• MMWR2007Notice to readers: recommendation from the advisory committee on immunization practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2–10 years at increased risk for invasive meningococcal diseaseMMWR Morb Mortal Wkly Rep5612656
   Google Scholar
• MMWR2008Emergence of fluoroquinolone-resistant Neisseria meningitidis – Minnesota and North Dakota, 2007–2008MMWR Morb Mortal Wkly Rep57173518288075
   PubMedGoogle Scholar
• NealKRNguyen-Van-TamJS2000Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional studyBMJ320846910731181
   PubMed Web of Science ®Google Scholar
• O’HallahanJLennonD2004The strategy to control New Zealand’s epidemic of group B meningococcal diseasePediatr Infect Dis J2312 SupplS293815597072
   PubMedGoogle Scholar
• PichicheroMCaseyJ2005Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old childrenPediatr Infect Dis J24576215665711
   PubMed Web of Science ®Google Scholar
• PichicheroMPapaT2006Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccinePediatr Infect Dis J25995100017072120
   PubMed Web of Science ®Google Scholar
• PollardAJ2004Global epidemiology of meningococcal disease and vaccine efficacyPediatr Infect Dis J2312 SupplS274915597069
   PubMedGoogle Scholar
• PollardAJFraschC2001Development of natural immunity to Neisseria meningitidisVaccine1913274611163654
   PubMed Web of Science ®Google Scholar
• RamsayMEAndrewsN2001Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in EnglandLancet357195611213098
   PubMed Web of Science ®Google Scholar
• RamsayMEAndrewsNJ2003Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysisBMJ326365612586669
   PubMed Web of Science ®Google Scholar
• RennelsMKingJJr2004Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infantsPediatr Infect Dis J234293515131466
   PubMed Web of Science ®Google Scholar
• RosensteinNLevineO1998Efficacy of meningococcal vaccine and barriers to vaccinationJAMA27943599466635
   PubMed Web of Science ®Google Scholar
• RosensteinNEPerkinsBA2001Meningococcal diseaseN Engl J Med34413788811333996
   PubMed Web of Science ®Google Scholar
• ScottRDMeltzerMJ2002Vaccinating first-year college students living in dormitories for meningococcal diseaseAm J Prev Med239810512121797
   PubMed Web of Science ®Google Scholar
• ShepardCWOrtega-SanchezIR2005Cost-effectiveness of conjugate meningococcal vaccination strategies in the United StatesPediatrics11512203215867028
   PubMed Web of Science ®Google Scholar
• SnapeMDKellyDF2005Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccinePediatr Infect Dis J241283115702040
   PubMed Web of Science ®Google Scholar
• TrotterCLAndrewsNJ2004Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introductionLancet364365715276396
   PubMed Web of Science ®Google Scholar
• van DeurenMBrandtzaegP2000Update on meningococcal disease with emphasis on pathogenesis and clinical managementClin Microbiol Rev131446610627495
   PubMed Web of Science ®Google Scholar
• YazdankhahSPKrizP2004Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and NorwayJ Clin Microbiol4251465315528708
   PubMed Web of Science ®Google Scholar